Diagnostic Value of 3D-Gradient Echo Dynamic Contrast Enhanced MRI in Breast Cancer.
10.3348/jkrs.1997.37.4.757
- Author:
Ik YANG
1
;
Soo Young CHUNG
;
Hai Jung PARK
;
Yul LEE
;
Bong Wha CHUNG
;
Jeong Won SHIM
Author Information
1. Department of Radiology, College of Medicine, Hallym University.
- Publication Type:Original Article
- Keywords:
Breast, MR;
Breast, neoplasm, diagnosis
- MeSH:
Breast Neoplasms*;
Breast*;
Diagnosis;
Fibroadenoma;
Gadolinium DTPA;
Healthy Volunteers;
Magnetic Resonance Imaging*;
Necrosis;
Retrospective Studies
- From:Journal of the Korean Radiological Society
1997;37(4):757-762
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To assess the usefulness of 3D-gradient echo dynamic contrast enhanced MRI (3D-DMRI) in the diagnosis of breast cancer and to determine the most useful parameter for this diagnosis. MATERIALS AND METHODS: Using a 1.0T MR unit, (Magnetom, Siemens, Erlaugen, Germany), 3D-DMRI (TR/TE=30/12) with Gd-DTPA was performed in 38 cases of breast cancer, 22 of fibroadenoma, and in three normal volunteers. We retrospectively evaluated the findings according to the speed on dynamic study and maximal amount of contrast enhancement during the delayed phase; we calculated the contrast index and morphology of the cancers and compared diagnostic accuracy among these three diagnostic parameters. RESULTS: On conventional spin-echo T1- and T2-weighted images, there was no significant difference of signal intensity between benign fibroadenoma and breast carcinoma. Rapid contrast enhancement (within one minute) was noted in 35 breast cancer lesions (92.1%), but relatively low and slow contrast enhancement (after five minutes) was noted in three such lesions (7.9%). Gradual contrast enhancement was noted in 21 lesions of fibroadenoma (95.5%), but a moderate degree of rapid contrast enhancement (from three to five minutes) was noted in the other case (7.9%). of On the delayed enhanced phase of 3D-DMRI, the maximal amountof contrast enhancement showed no significant difference between fibroadenoma and cancer. On 3D-DMRI, an irregular, spiculated border, with high contrast enhancement was noted in all cases of breast cancer, in particular, irregular thick peripheral contrast enhancement with central necrosis was noted 11 cases (28.9%). CONCLUSION: For the diagnosis of breast cancer, 3D-DMRI is a useful technique. Among the diagnostic criteria of speed, maximal amount of contrast enhancement and morphology, morphologic change after contrast enhancement study was the most useful diagnostic parameter.
